Loading...

Dana Goldman, PhD

TitleDistinguished Professor of Pharmacy, Public Policy, and Economics, and Leonard D. Schaeffer Director's Chair
InstitutionUniversity of Southern California
DepartmentPublic Policy
AddressVPD 412A
University Park Campus
Los Angeles CA 90089-7273
Phone+1 213 821 7948
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dana Goldman is a Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics. Until Fall 2009, he held RAND’s Distinguished Chair in Health Economics and directed RAND’s program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA.

    Dr. Goldman is a nationally-recognized health economist influential in both academic and policy circles. He is the author of over 100 articles and book chapters, including articles in some of the most prestigious medical, economic, health policy, and statistics journals. He is a health policy advisor to the Congressional Budget Office, and is a frequent speaker on health care issues. He serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is also a founding editor of the Forum for Health Economics and Policy, an online journal devoted to health economics and health policy.

    Dr. Goldman’s work has been featured in the New York Times, Wall Street Journal, Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media. Dr. Goldman was the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy. He was awarded the National Institute for Health Care Management Research Foundation award for excellence in health policy, and the Alice S. Hersh New Investigator Award recognizing the contributions of a young scholar to the field of health services research. He also has served on several panels for the National Academy of Sciences and Institute of Medicine, including a current panel on the fiscal future of the United States.

    Dr. Goldman’s research sponsors include the National Institutes of Health, National Institute on Aging, National Cancer Institute, National Science Foundation, Amgen, Merck, Genentech, Pfizer, UnitedHealth, Pacificare, California Healthcare Foundation, Smith Richardson Foundation, Department of Defense, Department of Labor, and the Agency for Healthcare Research and Quality.

    Dr. Goldman is also a research associate with the National Bureau of Economic Research, the nation’s leading economic research organization. He is the director of the RAND/UCLA Health Services Research Postdoctoral Training Program. He is also a founder and managing director of Precision Health Economics, a consulting firm to the health care industry. Dr. Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.


    Collapse Research 
    Collapse Research Activities and Funding
    Understanding and Modeling Innovation in Alzheimer?s Disease
    NIH/NIA R56AG052949Sep 30, 2016 - Aug 31, 2017
    Role: Principal Investigator
    The Long-Term Benefits of Interventions to Improve T2D Outcomes
    NIH/NIDDK R01DK107552Jul 22, 2016 - Jun 30, 2020
    Role: Principal Investigator
    One year day-and-night home closed loop in young people with type 1 diabetes
    NIH/NIDDK UC4DK108520Sep 30, 2015 - Sep 29, 2018
    Role: Co-Principal Investigator
    Technological Innovation in Health Care and the Long-Term Fiscal Outlook
    NIH/NIA R56AG045135Sep 15, 2014 - Jun 30, 2015
    Role: Principal Investigator
    Transforming Research and Clinical Knowledge in Traumatic Brain Injury
    NIH/NINDS U01NS086090Sep 30, 2013 - Aug 31, 2018
    Role: Co-Principal Investigator
    USC Resource Center for Minority Aging Research (US-RCMAR)
    NIH/NIA P30AG043073Sep 1, 2012 - Jun 30, 2018
    Role: Principal Investigator
    AN ECONOMIC AND BEHAVIORAL EVALUATION OF MEDICARE PART D
    NIH/NIA P01AG033559Sep 15, 2011 - Aug 31, 2016
    Role: Principal Investigator
    The Science of Medicare Reform
    NIH/NIA RC4AG039036Sep 30, 2010 - Aug 31, 2013
    Role: Co-Principal Investigator
    ECONOMICS OF TREATING VIRAL STIs
    NIH/NICHD R01HD054877Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Private Insurance and Prescription Outcomes for Children
    NIH/NICHD R03HD058203Jun 1, 2009 - May 31, 2012
    Role: Principal Investigator
    Improving Pharmacy Benefit Design
    NIH/NIA R01AG029514Sep 1, 2008 - Jul 31, 2013
    Role: Principal Investigator
    Obesity Among Older Americans
    NIH/NIA R01AG025743Jun 15, 2006 - May 31, 2012
    Role: Principal Investigator
    ROYBAL CENTER FOR HEALTH POLICY SIMULATION
    NIH/NIA P30AG024968Sep 30, 2004 - May 31, 2019
    Role: Principal Investigator
    AN INVESTIGATION OF THE VIATICAL SETTLEMENTS MARKET
    NIH/NIA R01AG022351Sep 15, 2003 - Aug 31, 2007
    Role: Principal Investigator
    State and Federal Policy and Outcomes for HIV+ Adults
    AHRQ R01HS010846Sep 30, 2001 - Apr 30, 2005
    Role: Principal Investigator
    RAND Mini-Medical School for Social Scientists
    NIH/NIA R13AG018327Sep 15, 2000 - Nov 30, 2018
    Role: Co-Principal Investigator
    HMO COST PERFORMANCE: A SIMULTANEOUS EQUATIONS APPROACH
    AHRQ R03HS007490Sep 1, 1992 - Aug 31, 1994
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chen C, Goldman DP, Zissimopoulos J, Rowe JW. Multidimensional comparison of countries' adaptation to societal aging. Proc Natl Acad Sci U S A. 2018 Aug 28. PMID: 30154160.
      View in: PubMed
    2. Cefalu WT, Dawes DE, Gavlak G, Goldman D, Herman WH, Van Nuys K, Powers AC, Taylor SI, Yatvin AL. Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311. Diabetes Care. 2018 Jun 28. PMID: 29954841.
      View in: PubMed
    3. Cefalu WT, Dawes DE, Gavlak G, Goldman D, Herman WH, Van Nuys K, Powers AC, Taylor SI, Yatvin AL. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care. 2018 May 08. PMID: 29739814.
      View in: PubMed
    4. Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, Goldman DP. Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS One. 2018; 13(4):e0195088. PMID: 29649277.
      View in: PubMed
    5. Goldman DP, Fillit H, Neumann P. Accelerating Alzheimer's disease drug innovations from the research pipeline to patients. Alzheimers Dement. 2018 Mar 23. PMID: 29680407.
      View in: PubMed
    6. Van Nuys K, Joyce G, Ribero R, Goldman DP. Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs. JAMA. 2018 03 13; 319(10):1045-1047. PMID: 29536088.
      View in: PubMed
    7. Kabiri M, Brauer M, Shafrin J, Sullivan J, Gill TM, Goldman DP. Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States. Value Health. 2018 Jul; 21(7):792-798. PMID: 30005751.
      View in: PubMed
    8. Chen AJ, Goldman DP. Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials. Value Health. 2018 Aug; 21(8):905-910. PMID: 30098667.
      View in: PubMed
    9. Jena AB, Olenski A, Blumenthal DM, Yeh RW, Goldman DP, Romley J. Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings. J Am Heart Assoc. 2018 Mar 09; 7(6). PMID: 29523525.
      View in: PubMed
    10. Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities. JACC Heart Fail. 2018 May; 6(5):401-409. PMID: 29525333.
      View in: PubMed
    11. Goldman DP, Chen C, Zissimopoulos J, Rowe JW. Opinion: Measuring how countries adapt to societal aging. Proc Natl Acad Sci U S A. 2018 Jan 16; 115(3):435-437. PMID: 29339547.
      View in: PubMed
    12. Sachs RE, Ginsburg PB, Goldman DP. Encouraging New Uses for Old Drugs. JAMA. 2017 Dec 26; 318(24):2421-2422. PMID: 29204602.
      View in: PubMed
    13. Gonzalez-Gonzalez C, Tysinger B, Goldman DP, Wong R. Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico). BMJ Open. 2017 Oct 25; 7(10):e017330. PMID: 29074514.
      View in: PubMed
    14. Blumenthal DM, Goldman D, Jena AB. Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors. JAMA Cardiol. 2017 Oct 01; 2(10):1063-1064. PMID: 28854318.
      View in: PubMed
    15. Shafrin J, Sullivan J, Goldman DP, Gill TM. The association between observed mobility and quality of life in the near elderly. PLoS One. 2017; 12(8):e0182920. PMID: 28827806.
      View in: PubMed
    16. St Clair P, Gaudette É, Zhao H, Tysinger B, Seyedin R, Goldman DP. Using Self-reports or Claims to Assess Disease Prevalence: It's Complicated. Med Care. 2017 Aug; 55(8):782-788. PMID: 28617703.
      View in: PubMed
    17. Cheng WH, Gaudette É, Goldman DP. PCSK9 Inhibitors Show Value for Patients and the US Health Care System. Value Health. 2017 12; 20(10):1270-1278. PMID: 29241886.
      View in: PubMed
    18. Zissimopoulos J, Blaylock B, Goldman DP, Rowe JW. Raising the Social Security Entitlement Age. Res Aging. 2017 01; 39(1):166-189. PMID: 28181866.
      View in: PubMed
    19. Woo K, Gascue L, Goldman DP, Romley JA. Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly. J Vasc Surg. 2017 Mar; 65(3):783-792.e4. PMID: 28027805.
      View in: PubMed
    20. Blumenthal DM, Goldman DP, Jena AB. Outcomes-Based Pricing as a Tool to Ensure Access to Novel but Expensive Biopharmaceuticals. Ann Intern Med. 2017 02 07; 166(3):219-220. PMID: 27951598.
      View in: PubMed
    21. Agus DB, Gaudette É, Goldman DP, Messali A. The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older. PLoS One. 2016; 11(11):e0166103. PMID: 27902693.
      View in: PubMed
    22. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A. Authors' reply to Bosco-Lévy and Salvo. BMJ. 2016 Aug 05; 354:i4330. PMID: 27496026.
      View in: PubMed
    23. Jena AB, Goldman D, Karaca-Mandic P. Hospital Prescribing of Opioids to Medicare Beneficiaries. JAMA Intern Med. 2016 07 01; 176(7):990-7. PMID: 27294595.
      View in: PubMed
    24. Jena AB, Blumenthal DM, Stevens W, Chou JW, Ton TG, Goldman DP. Value of improved lipid control in patients at high risk for adverse cardiac events. Am J Manag Care. 2016 Jun 01; 22(6):e199-207. PMID: 27355907.
      View in: PubMed
    25. Thornton Snider J, Seabury S, Lopez J, McKenzie S, Goldman DP. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs. Am J Manag Care. 2016 Jun; 22(6):433-40. PMID: 27355811.
      View in: PubMed
    26. Goldman DP, Gaudette É, Cheng WH. Competing Risks: Investing in Sickness Rather Than Health. Am J Prev Med. 2016 May; 50(5 Suppl 1):S45-S50. PMID: 27102858.
      View in: PubMed
    27. Goldman D. The Economic Promise of Delayed Aging. Cold Spring Harb Perspect Med. 2015 Dec 18; 6(2):a025072. PMID: 26684333.
      View in: PubMed
    28. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A. Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis. BMJ. 2015 Dec 07; 351:h6223. PMID: 26643108; PMCID: PMC4670968.
    29. Gaudette É, Tysinger B, Cassil A, Goldman DP. Health and Health Care of Medicare Beneficiaries in 2030. Forum Health Econ Policy. 2015 Dec; 18(2):75-96. PMID: 27127455.
      View in: PubMed
    30. Snider JT, Goldman DP, Rosenblatt L, Seekins D, Juday T, Sanchez Y, Wu Y, Peneva D, Romley JA. The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV. Med Care Res Rev. 2016 06; 73(3):329-48. PMID: 26537525.
      View in: PubMed
    31. Van Nuys K, Brookmeyer R, Chou JW, Dreyfus D, Dieterich D, Goldman DP. Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A Concern. Health Aff (Millwood). 2015 Oct; 34(10):1666-74. PMID: 26438742.
      View in: PubMed
    32. Nikolich-Žugich J, Goldman DP, Cohen PR, Cortese D, Fontana L, Kennedy BK, Mohler MJ, Olshansky SJ, Perls T, Perry D, Richardson A, Ritchie C, Wertheimer AM, Faragher RG, Fain MJ. Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society. J Gerontol A Biol Sci Med Sci. 2016 Apr; 71(4):435-44. PMID: 26419976; PMCID: PMC5014189 [Available on 04/01/17].
    33. Woo K, Goldman DP, Romley JA. Early Failure of Dialysis Access among the Elderly in the Era of Fistula First. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1791-8. PMID: 26254301; PMCID: PMC4594075 [Available on 10/07/16].
    34. Jena AB, Ho O, Goldman DP, Karaca-Mandic P. The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma. JAMA Intern Med. 2015 Jul; 175(7):1171-9. PMID: 25962128; PMCID: PMC4494980.
    35. Gaudette É, Goldman DP, Messali A, Sood N. Do Statins Reduce the Health and Health Care Costs of Obesity? Pharmacoeconomics. 2015 Jul; 33(7):723-34. PMID: 25576147; PMCID: PMC4490078.
    36. Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, Wiederkehr D, Trocio J. Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States. Am J Cardiol. 2015 Sep 01; 116(5):733-9. PMID: 26138378.
      View in: PubMed
    37. Seabury SA, Lakdawalla DN, Dougherty JS, Sullivan J, Goldman DP. Medication adherence and measures of health plan quality. Am J Manag Care. 2015 Jun 01; 21(6):e379-89. PMID: 26247579.
      View in: PubMed
    38. Romley JA, Goldman DP, Sood N. Hospital Productivity: The Authors Reply. Health Aff (Millwood). 2015 Jun; 34(6):1069. PMID: 26056222.
      View in: PubMed
    39. Eber MR, Goldman DP, Lakdawalla DN, Philipson TJ, Pritchard D, Huesch M, Summers N, Linthicum MT, Sullivan J, Dubois RW. Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. J Comp Eff Res. 2015 May 07; 1-11. PMID: 25951244.
      View in: PubMed
    40. Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to fulfil the promise of personalised medicine. Lancet. 2015 May 23; 385(9982):2118-9. PMID: 25957453.
      View in: PubMed
    41. Lakdawalla DN, Chou JW, Linthicum MT, MacEwan JP, Zhang J, Goldman DP. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer. JAMA Oncol. 2015 May; 1(2):196-202. PMID: 26181023.
      View in: PubMed
    42. Jena AB, Goldman DP, Seabury SA. Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Intern Med. 2015 Apr; 175(4):617-23. PMID: 25664968; PMCID: PMC4465086.
    43. Stevens W, Philipson TJ, Khan ZM, MacEwan JP, Linthicum MT, Goldman DP. Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995-2007. Health Aff (Millwood). 2015 Apr; 34(4):562-70. PMID: 25847637.
      View in: PubMed
    44. Romley JA, Goldman DP, Sood N. US hospitals experienced substantial productivity growth during 2002-11. Health Aff (Millwood). 2015 Mar; 34(3):511-8. PMID: 25673334.
      View in: PubMed
    45. Zissimopoulos J, Joyce GF, Scarpati LM, Goldman DP. Did Medicare Part D reduce disparities? Am J Manag Care. 2015 Feb; 21(2):119-28. PMID: 25880361; PMCID: PMC4405127.
    46. Jena AB, Prasad V, Goldman DP, Romley J. Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings. JAMA Intern Med. 2015 Feb; 175(2):237-44. PMID: 25531231; PMCID: PMC4314435.
    47. Chandra A, Snider JT, Wu Y, Jena A, Goldman DP. Robot-assisted surgery for kidney cancer increased access to a procedure that can reduce mortality and renal failure. Health Aff (Millwood). 2015 Feb; 34(2):220-8. PMID: 25646101.
      View in: PubMed
    48. Romley JA, Axeen S, Lakdawalla DN, Chernew ME, Bhattacharya J, Goldman DP. The Relationship between Commercial Health Care Prices and Medicare Spending and Utilization. Health Serv Res. 2015 Jun; 50(3):883-96. PMID: 25429755; PMCID: PMC4450935.
    49. Trish E, Joyce G, Goldman DP. Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11. Health Aff (Millwood). 2014 Nov; 33(11):2018-24. PMID: 25367998; PMCID: PMC4250050.
    50. Goldman DP, Philipson T. Five myths about cancer care in America. Health Aff (Millwood). 2014 Oct; 33(10):1801-4. PMID: 25288425.
      View in: PubMed
    51. Goldman D, Fastenau J, Dirani R, Helland E, Joyce G, Conrad R, Lakdawalla D. Medicaid prior authorization policies and imprisonment among patients with schizophrenia. Am J Manag Care. 2014 Jul; 20(7):577-86. PMID: 25295404.
      View in: PubMed
    52. Goldman DP, Orszag PR. The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare. Am Econ Rev. 2014 May; 104(5):230-233. PMID: 27127305.
      View in: PubMed
    53. Van Nuys K, Globe D, Ng-Mak D, Cheung H, Sullivan J, Goldman D. The association between employee obesity and employer costs: evidence from a panel of U.S. employers. Am J Health Promot. 2014 May-Jun; 28(5):277-85. PMID: 24779722.
      View in: PubMed
    54. Barcellos SH, Wuppermann AC, Carman KG, Bauhoff S, McFadden DL, Kapteyn A, Winter JK, Goldman D. Preparedness of Americans for the Affordable Care Act. Proc Natl Acad Sci U S A. 2014 Apr 15; 111(15):5497-502. PMID: 24706843; PMCID: PMC3992693.
    55. Snider JT, Juday T, Romley JA, Seekins D, Rosenblatt L, Sanchez Y, Goldman DP. Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Aff (Millwood). 2014 Mar; 33(3):386-93. PMID: 24590935.
      View in: PubMed
    56. Ryan GW, Bloom EW, Lowsky DJ, Linthicum MT, Juday T, Rosenblatt L, Kulkarni S, Goldman DP, Sayles JN. Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood). 2014 Mar; 33(3):410-7. PMID: 24590938.
      View in: PubMed
    57. Goldman DP, Juday T, Linthicum MT, Rosenblatt L, Seekins D. The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood). 2014 Mar; 33(3):428-33. PMID: 24590941.
      View in: PubMed
    58. Goldman DP, Dirani R, Fastenau J, Conrad RM. Do strict formularies replicate failure for patients with schizophrenia? Am J Manag Care. 2014 Mar; 20(3):219-28. PMID: 24884751.
      View in: PubMed
    59. Romley JA, Juday T, Solomon MD, Seekins D, Brookmeyer R, Goldman DP. Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. Health Aff (Millwood). 2014 Mar; 33(3):370-7. PMID: 24590933.
      View in: PubMed
    60. Goldman DP, Juday T, Seekins D, Linthicum MT, Romley JA. Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood). 2014 Mar; 33(3):362-9. PMID: 24590932; PMCID: PMC4124881.
    61. Sood N, Juday T, Vanderpuye-Orgle J, Rosenblatt L, Romley JA, Peneva D, Goldman DP. HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood). 2014 Mar; 33(3):394-400. PMID: 24590936.
      View in: PubMed
    62. Jena AB, Goldman D, Weaver L, Karaca-Mandic P. Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ. 2014 Feb 19; 348:g1393. PMID: 24553363; PMCID: PMC3928962.
    63. Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care. 2014 Feb 01; 20(2):e52-60. PMID: 24738555.
      View in: PubMed
    64. Basu A, Jena AB, Goldman DP, Philipson TJ, Dubois R. Response to Epstein's comment on "heterogeneity in action". Health Econ. 2014 Mar; 23(3):376-8. PMID: 24446313.
      View in: PubMed
    65. Snider JT, Bognar K, Globe D, Ng-Mak D, Sullivan J, Summers N, Goldman D. Identifying patients at risk for high medical costs and good candidates for obesity intervention. Am J Health Promot. 2014 Mar-Apr; 28(4):218-27. PMID: 24359175.
      View in: PubMed
    66. Goldman DP, McFadden D, Newhouse JP. Introduction. Standard market mechanisms than does traditional Medicare. J Health Econ. 2013 Dec; 32(6):1258-62. PMID: 24308877.
      View in: PubMed
    67. Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014 Jun; 69(6):640-9. PMID: 24249734; PMCID: PMC4022100.
    68. Romley JA, Chen AY, Goldman DP, Williams R. Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res. 2014 Apr; 49(2):588-608. PMID: 24138064; PMCID: PMC3976188.
    69. Basu A, Jena AB, Goldman DP, Philipson TJ, Dubois R. Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ. 2014 Mar; 23(3):359-73. PMID: 24123568; PMCID: PMC4282978.
    70. Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood). 2013 Oct; 32(10):1698-705. PMID: 24101058; PMCID: PMC3938188.
    71. Jena AB, Sun E, Goldman D. Community-acquired pneumonia and proton pump inhibitors. J Gen Intern Med. 2013 Jul; 28(7):874-5. PMID: 23549958; PMCID: PMC3682033.
    72. Goldman D, Maestas N. MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE. J Appl Econ (Chichester Engl). 2013 Jun 01; 28(4):527-550. PMID: 23997424.
      View in: PubMed
    73. Joyce GF, Zissimopoulos J, Goldman DP. Digesting the doughnut hole. J Health Econ. 2013 Dec; 32(6):1345-55. PMID: 24308883; PMCID: PMC3855661.
    74. Eibner C, Goldman DP, Sullivan J, Garber AM. Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood). 2013 May; 32(5):891-9. PMID: 23650322; PMCID: PMC3886857.
    75. Lakdawalla D, Eber MR, Forma FM, Sullivan J, Michaud PC, Bradley LA, Goldman DP. Measuring the value of better diabetes management. Am J Manag Care. 2013 Mar-Apr; 19 Spec No. 2:E11. PMID: 23725237.
      View in: PubMed
    76. Romley JA, Jena AB, O'Leary JF, Goldman DP. Spending and mortality in US acute care hospitals. Am J Manag Care. 2013 Feb 01; 19(2):e46-54. PMID: 23448114; PMCID: PMC3989348.
    77. Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013 Feb; 19(2):121-8. PMID: 23448109.
      View in: PubMed
    78. Chernew ME, McKellar R, Aubry W, Beck R, Benner J, Berger JE, Fendrick AM, Forma F, Goldman D, Peters Harmel A, Killion R, Lakdawalla D, Owens DK, Stahl J. Comparative effectiveness research and formulary placement: the case of diabetes. Am J Manag Care. 2013 Feb; 19(2):93-6. PMID: 23448106.
      View in: PubMed
    79. Barcellos SH, Goldman DP, Smith JP. Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. Health Aff (Millwood). 2012 Dec; 31(12):2727-37. PMID: 23213157; PMCID: PMC3645344.
    80. Perlroth DJ, Bhattacharya J, Goldman DP, Garber AM. An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):250-7. PMID: 23271781; PMCID: PMC3540871.
    81. Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Curr Med Res Opin. 2012 Dec; 28(12):1959-67. PMID: 23098081.
      View in: PubMed
    82. Darkow T, Maclean R, Joyce GF, Goldman D, Lakdawalla DN. Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. Am J Manag Care. 2012 Nov; 18(11 Suppl):S272-8. PMID: 23327459.
      View in: PubMed
    83. Grabowski DC, Lakdawalla DN, Goldman DP, Eber M, Liu LZ, Abdelgawad T, Kuznik A, Chernew ME, Philipson T. The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood). 2012 Oct; 31(10):2276-85. PMID: 23048109.
      View in: PubMed
    84. Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med. 2013 Feb; 28(2):223-30. PMID: 22956446; PMCID: PMC3614140.
    85. Best JH, Romley JA, Goldman DP, Conrad RM, Peters AL. Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. Am J Manag Care. 2012 Sep; 18(8 Suppl):s191-202. PMID: 23039898.
      View in: PubMed
    86. Romley JA, Hackbarth A, Goldman DP. The Impact of Air Quality on Hospital Spending. Rand Health Q. 2012; 2(3):6. PMID: 28083265.
      View in: PubMed
    87. Olshansky SJ, Antonucci T, Berkman L, Binstock RH, Boersch-Supan A, Cacioppo JT, Carnes BA, Carstensen LL, Fried LP, Goldman DP, Jackson J, Kohli M, Rother J, Zheng Y, Rowe J. Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood). 2012 Aug; 31(8):1803-13. PMID: 22869659.
      View in: PubMed
    88. Romley J, Goldman D, Eber M, Dastani H, Kim E, Raparla S. Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis. Am J Manag Care. 2012 Aug; 18(8):460-4. PMID: 22928761.
      View in: PubMed
    89. Romley JA, Goldman DP, Solomon M, McFadden D, Peters AL. Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther. 2012 Oct; 14(10):904-11. PMID: 22845701; PMCID: PMC3513976.
    90. Thornton Snider J, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The Disability burden of COPD. COPD. 2012 Aug; 9(5):513-21. PMID: 22721264.
      View in: PubMed
    91. Michaud PC, Goldman DP, Lakdawalla DN, Zheng Y, Gailey AH. The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ. 2012 Jul; 31(4):630-43. PMID: 22705389; PMCID: PMC3600147.
    92. Romley JA, Sanchez Y, Penrod JR, Goldman DP. Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. Health Aff (Millwood). 2012 Apr; 31(4):683-90. PMID: 22492884.
      View in: PubMed
    93. Seabury SA, Goldman DP, Maclean JR, Penrod JR, Lakdawalla DN. Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood). 2012 Apr; 31(4):691-9. PMID: 22492885.
      View in: PubMed
    94. Philipson T, Eber M, Lakdawalla DN, Corral M, Conti R, Goldman DP. An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood). 2012 Apr; 31(4):667-75. PMID: 22492882; PMCID: PMC3829769.
    95. Karaca-Mandic P, Jena AB, Joyce GF, Goldman DP. Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA. 2012 Mar 28; 307(12):1284-91. PMID: 22453569; PMCID: PMC3754900.
    96. Huckfeldt PJ, Meeker D, Peters A, Guterman JJ, Diaz G, Goldman DP. Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. Health Aff (Millwood). 2012 Jan; 31(1):168-76. PMID: 22232107; PMCID: PMC3883628.
    97. Jena AB, Goldman DP, Foster SE, Califano JA. Prescription medication abuse and illegitimate internet-based pharmacies. Ann Intern Med. 2011 Dec 20; 155(12):848-50. PMID: 22184692.
      View in: PubMed
    98. Vogt WB, Joyce G, Xia J, Dirani R, Wan G, Goldman DP. Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. Health Aff (Millwood). 2011 Dec; 30(12):2346-54. PMID: 22147863; PMCID: PMC3883626.
    99. Joyce GF, Carrera MP, Goldman DP, Sood N. Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care. 2011 Dec 01; 17(12):e462-71. PMID: 22216870; PMCID: PMC3782257.
    100. Chernew M, Goldman D, Axeen S. How much savings can we wring from Medicare? N Engl J Med. 2011 Oct 06; 365(14):e29. PMID: 21991979.
      View in: PubMed
    101. Hackbarth AD, Romley JA, Goldman DP. Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards. Soc Sci Med. 2011 Oct; 73(8):1163-8. PMID: 21893376.
      View in: PubMed
    102. Michaud PC, Goldman D, Lakdawalla D, Gailey A, Zheng Y. Differences in health between Americans and Western Europeans: Effects on longevity and public finance. Soc Sci Med. 2011 Jul; 73(2):254-63. PMID: 21719178.
      View in: PubMed
    103. Jena AB, Goldman DP. Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood). 2011 Jun; 30(6):1192-9. PMID: 21565838; PMCID: PMC3884823.
    104. Goldman DP, Joyce GF, Vogt WB. Part D Formulary and Benefit Design as a Risk-Steering Mechanism. Am Econ Rev. 2011 May; 101(3):382-386. PMID: 25067840.
      View in: PubMed
    105. Goldman D, Smith JP. The increasing value of education to health. Soc Sci Med. 2011 May; 72(10):1728-37. PMID: 21555176; PMCID: PMC3119491.
    106. Jena AB, Goldman DP, Joyce G. Association between the birth of twins and parental divorce. Obstet Gynecol. 2011 Apr; 117(4):892-7. PMID: 21422862; PMCID: PMC3069855.
    107. Goldman DP, Zissimopoulos J, Lu Y. Medical Expenditure Measures in the Health and Retirement Study. Forum Health Econ Policy. 2011 Apr 01; 14(3):4. PMID: 24049512.
      View in: PubMed
    108. Romley JA, Jena AB, Goldman DP. Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med. 2011 Feb 01; 154(3):160-7. PMID: 21282695; PMCID: PMC3782295.
    109. Goldman DP, Lakdawalla DN, Malkin JD, Romley J, Philipson T. The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data. Health Aff (Millwood). 2011 Jan; 30(1):84-90. PMID: 21209443; PMCID: PMC3804334.
    110. Baicker K, Goldman D. Patient cost-sharing and healthcare spending growth. J Econ Perspect. 2011; 25(2):47-68. PMID: 21595325.
      View in: PubMed
    111. Romley JA, Goldman DP. How costly is hospital quality? A revealed-preference approach. J Ind Econ. 2011; 59(4):578-608. PMID: 22299199; PMCID: PMC3989349.
    112. Goldman DP, Vaiana M, Romley JA. The emerging importance of patient amenities in hospital care. N Engl J Med. 2010 Dec 02; 363(23):2185-7. PMID: 21121830; PMCID: PMC4023463.
    113. Antos J, Bertko J, Chernew M, Cutler D, de Brantes F, Goldman D, Kocher B, McClellan M, McGlynn E, Pauly M, Shortell S. Bending the curve through health reform implementation. Am J Manag Care. 2010 Nov; 16(11):804-12. PMID: 21348552.
      View in: PubMed
    114. Meeker D, Joyce GF, Malkin J, Teutsch SM, Haddix AC, Goldman DP. Coverage and preventive screening. Health Serv Res. 2011 Feb; 46(1 Pt 1):173-84. PMID: 21029084; PMCID: PMC3034268.
    115. Goldman D, Lakdawalla D, Philipson TJ, Yin W. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. Health Econ. 2010 Oct; 19(10):1109-16. PMID: 20842680.
      View in: PubMed
    116. Karaca-Mandic P, Joyce GF, Goldman DP, Laouri M. Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res. 2010 Oct; 45(5 Pt 1):1227-50. PMID: 20831715; PMCID: PMC2965502.
    117. Jena AB, Goldman DP, Kamdar A, Lakdawalla DN, Lu Y. Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med. 2010 Jul 06; 153(1):1-7. PMID: 20621899; PMCID: PMC3673772.
    118. Smith JP, Goldman D. Can patient self-management explain the health gradient? Goldman and Smith (2002) revisited: a response to Maitra. Soc Sci Med. 2010 Mar 01; 70(6):813-5. PMID: 20661311; PMCID: PMC2908910.
    119. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldman DP, Philipson TJ. An economic evaluation of the war on cancer. J Health Econ. 2010 May; 29(3):333-46. PMID: 20363520.
      View in: PubMed
    120. Perlroth DJ, Goldman DP, Garber AM. The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography. 2010; 47 Suppl:S173-90. PMID: 21302424.
      View in: PubMed
    121. Olshansky SJ, Goldman DP, Zheng Y, Rowe JW. Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q. 2009 Dec; 87(4):842-62. PMID: 20021588; PMCID: PMC2888016.
    122. Goldman DP, Jena AB, Lakdawalla DN, Malin JL, Malkin JD, Sun E. The value of specialty oncology drugs. Health Serv Res. 2010 Feb; 45(1):115-32. PMID: 19878344; PMCID: PMC2813440.
    123. Antos J, Bertko J, Chernew M, Cutler D, Goldman D, McClellan M, McGlynn E, Pauly M, Schaeffer L, Shortell S. Bending the curve: effective steps to address long-term healthcare spending growth. Am J Manag Care. 2009 Oct; 15(10):676-80. PMID: 19845419.
      View in: PubMed
    124. Bhattacharya J, Goldman D, Sood N. MARKET EVIDENCE OF MISPERCEIVED MORTALITY RISK. J Econ Behav Organ. 2009 Oct 01; 72(1):451-462. PMID: 23606779.
      View in: PubMed
    125. Goldman DP, Zheng Y, Girosi F, Michaud PC, Olshansky SJ, Cutler D, Rowe JW. The benefits of risk factor prevention in Americans aged 51 years and older. Am J Public Health. 2009 Nov; 99(11):2096-101. PMID: 19762651; PMCID: PMC2759785.
    126. Joyce GF, Goldman DP, Vogt WB, Sun E, Jena AB. Medicare part D after 2 years. Am J Manag Care. 2009 Aug; 15(8):536-44. PMID: 19670957; PMCID: PMC3767434.
    127. Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med. 2009 Apr 27; 169(8):740-8; discussion 748-9. PMID: 19398684; PMCID: PMC3875311.
    128. Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Jost TS, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Luft HS, Mashal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Silber BM, Skinner J, Shortell SM, Thier SO, Tunis S, Wulsin L, Yock P, Nun GB, Bryan S, Luxenburg O, van de Ven WP. Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med. 2009 Apr 07; 150(7):493-5. PMID: 19258550.
      View in: PubMed
    129. Sood N, de Vries H, Gutierrez I, Lakdawalla DN, Goldman DP. The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w125-37. PMID: 19088100; PMCID: PMC3829766.
    130. Lakdawalla DN, Goldman DP, Michaud PC, Sood N, Lempert R, Cong Z, de Vries H, Gutierrez I. U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w138-50. PMID: 19088101; PMCID: PMC3804349.
    131. Joyce GF, Goldman DP, Karaca-Mandic P, Lawless GD. Impact of specialty drugs on the use of other medical services. Am J Manag Care. 2008 Dec; 14(12):821-8. PMID: 19067499; PMCID: PMC3767569.
    132. Ruelas V, Roybal GM, Lu Y, Goldman D, Peters A. Clinical and behavioral correlates of achieving and maintaining glycemic targets in an underserved population with type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):54-6. PMID: 18931097; PMCID: PMC2606830.
    133. Goldman DP, Joyce GF. Medicare Part D: a successful start with room for improvement. JAMA. 2008 Apr 23; 299(16):1954-5. PMID: 18430916; PMCID: PMC3767428.
    134. Shang B, Goldman D. Does age or life expectancy better predict health care expenditures? Health Econ. 2008 Apr; 17(4):487-501. PMID: 17935199.
      View in: PubMed
    135. Goldman DP, Jena AB, Philipson T, Sun E. Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood). 2008 Jan-Feb; 27(1):122-9. PMID: 18180487; PMCID: PMC3756826.
    136. Garber A, Goldman DP, Jena AB. The promise of health care cost containment. Health Aff (Millwood). 2007 Nov-Dec; 26(6):1545-7. PMID: 17978370.
      View in: PubMed
    137. Joyce GF, Goldman DP, Karaca-Mandic P, Zheng Y. Pharmacy benefit caps and the chronically ill. Health Aff (Millwood). 2007 Sep-Oct; 26(5):1333-44. PMID: 17848444.
      View in: PubMed
    138. Buntin MB, Escarce JJ, Goldman D. Use of physicians' services for Medicare beneficiaries. N Engl J Med. 2007 Aug 09; 357(6):618; author reply 618-9. PMID: 17691130.
      View in: PubMed
    139. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007 Jul 04; 298(1):61-9. PMID: 17609491.
      View in: PubMed
    140. Kilgore ML, Goldman DP. Drug costs and out-of-pocket spending in cancer clinical trials. Contemp Clin Trials. 2008 Jan; 29(1):1-8. PMID: 17544339.
      View in: PubMed
    141. Goldman DP, Smith JP, Sood N. Immigrants and the cost of medical care. Health Aff (Millwood). 2006 Nov-Dec; 25(6):1700-11. PMID: 17102196.
      View in: PubMed
    142. Goldman DP, Joyce GF, Lawless G, Crown WH, Willey V. Benefit design and specialty drug use. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1319-31. PMID: 16966729.
      View in: PubMed
    143. Goldman DP, Sood N. Rising medicare costs: are we in crisis? Health Aff (Millwood). 2006 Sep-Oct; 25(5):w389-90; discussion w391-2. PMID: 16926181.
      View in: PubMed
    144. Bhattacharya J, Goldman D, McCaffrey D. Estimating probit models with self-selected treatments. Stat Med. 2006 Feb 15; 25(3):389-413. PMID: 16382420.
      View in: PubMed
    145. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care. 2006 Jan; 12(1):21-8. PMID: 16402885.
      View in: PubMed
    146. Goldman DP, Smith JP, Sood N. Legal status and health insurance among immigrants. Health Aff (Millwood). 2005 Nov-Dec; 24(6):1640-53. PMID: 16284039.
      View in: PubMed
    147. Smith JP. Socioeconomic Differences in the Adoption of New Medical Technologies. Am Econ Rev. 2005 May; 95(2):234-7. PMID: 29120591.
      View in: PubMed
    148. Joyce GF, Goldman DP, Leibowitz AA, Alpert A, Bao Y. A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved. 2005 Feb; 16(1):19-28. PMID: 15741706.
      View in: PubMed
    149. Goldman DP, Joyce GF. Moving towards better formulary management. Am J Manag Care. 2005 Jan; 11(1):13-4. PMID: 15697095.
      View in: PubMed
    150. Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF, Lakdawalla DN, Panis C, Shekelle PG. Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R5-17. PMID: 16186147.
      View in: PubMed
    151. Bhattacharya J, Shang B, Su CK, Goldman DP. Technological advances in cancer and future spending by the elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R53-66. PMID: 16186151.
      View in: PubMed
    152. Chernew ME, Goldman DP, Pan F, Shang B. Disability and health care spending among medicare beneficiaries. Health Aff (Millwood). 2005; 24 Suppl 2:W5R42-52. PMID: 16186150.
      View in: PubMed
    153. Lakdawalla DN, Goldman DP, Shang B. The health and cost consequences of obesity among the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R30-41. PMID: 16186149.
      View in: PubMed
    154. Shekelle PG, Ortiz E, Newberry SJ, Rich MW, Rhodes SL, Brook RH, Goldman DP. Identifying potential health care innovations for the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R67-76. PMID: 16186152.
      View in: PubMed
    155. Joyce GF, Keeler EB, Shang B, Goldman DP. The lifetime burden of chronic disease among the elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R18-29. PMID: 16186148.
      View in: PubMed
    156. Goldman DP, Bao Y. Effective HIV treatment and the employment of HIV(+) adults. Health Serv Res. 2004 Dec; 39(6 Pt 1):1691-712. PMID: 15533182; PMCID: PMC1361093.
    157. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004 May 19; 291(19):2344-50. PMID: 15150206.
      View in: PubMed
    158. Goldman DP, Leibowitz AA, Robalino DA. Employee responses to health insurance premium increases. Am J Manag Care. 2004 Jan; 10(1):41-7. PMID: 14738186.
      View in: PubMed
    159. Bui AA, Taira RK, Goldman D, Dionisio JD, Aberle DR, El-Saden S, Sayre J, Rice T, Kangarloo H. Effect of an imaging-based streamlined electronic healthcare process on quality and costs. Acad Radiol. 2004 Jan; 11(1):13-20. PMID: 14746397.
      View in: PubMed
    160. Malkin JD, Goldman DP, Joyce GF. The changing face of pharmacy benefit design. Health Aff (Millwood). 2004 Jan-Feb; 23(1):194-9. PMID: 15002642.
      View in: PubMed
    161. Buntin MJ, Escarcé JJ, Goldman D, Kan H, Laugesen MJ, Shekelle P. Increased Medicare expenditures for physicians' services: what are the causes? Inquiry. 2004; 41(1):83-94. PMID: 15224962.
      View in: PubMed
    162. Bhattacharya J, Cutler DM, Goldman DP, Hurd MD, Joyce GF, Lakdawalla DN, Panis CW, Shang B. Disability forecasts and future Medicare costs. Front Health Policy Res. 2004; 7:75-94. PMID: 15612336.
      View in: PubMed
    163. Lakdawalla DN, Bhattacharya J, Goldman DP. Are the young becoming more disabled? Health Aff (Millwood). 2004 Jan-Feb; 23(1):168-76. PMID: 15002639.
      View in: PubMed
    164. Bhattacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003 Nov; 22(6):1105-22. PMID: 14604563.
      View in: PubMed
    165. Goldman DP, Berry SH, McCabe MS, Kilgore ML, Potosky AL, Schoenbaum ML, Schonlau M, Weeks JC, Kaplan R, Escarce JJ. Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA. 2003 Jun 11; 289(22):2970-7. PMID: 12799405.
      View in: PubMed
    166. Goldman DP, Zissimopoulos JM. High out-of-pocket health care spending by the elderly. Health Aff (Millwood). 2003 May-Jun; 22(3):194-202. PMID: 12757285.
      View in: PubMed
    167. Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003 Apr 01; 21(7):1383-9. PMID: 12663731.
      View in: PubMed
    168. Lakdawalla D, Goldman DP, Bhattacharya J, Hurd MD, Joyce GF, Panis CW. Forecasting the nursing home population. Med Care. 2003 Jan; 41(1):8-20. PMID: 12544538.
      View in: PubMed
    169. Goldman DP, Leibowitz AA, Joyce GF, Fleishman JA, Bozzette SA, Duan N, Shapiro MF. Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Appl Health Econ Health Policy. 2003; 2(2):85-90. PMID: 14619279.
      View in: PubMed
    170. Lakdawalla D, Bhattacharya J, Goldman DP. A response to the points by Manton and Williamson. Med Care. 2003 Jan; 41(1):28-31. PMID: 12544541.
      View in: PubMed
    171. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002 Oct 09; 288(14):1733-9. PMID: 12365957.
      View in: PubMed
    172. Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10929-34. PMID: 12140364; PMCID: PMC125075.
    173. Goldman DP, Lakdawalla D. A new method for determining patient payments for outpatient drugs. Am J Manag Care. 2002 Feb; 8(2):125, 128, 130. PMID: 11853200.
      View in: PubMed